Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

NCT03479229 is registered in ClinicalTrials.gov with Viveve Inc. as lead sponsor.

NCT NCT03479229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03479229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy
Lead sponsor
Viveve Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 20, 2018
Completion date
March 15, 2020
Enrollment
250 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

female sexual dysfunction